In conjunction with their Chinese partners TPP Healthcare, EBM has recently launched a complementary Business Development service targeted at companies looking to build their business in China's high growth CHC market.
- Finding the right M&A targets and or Local company partners to work with in China and determining commercial potential, best route to market, regulatory feasibility, deal structure/business model and commercialisation strategy, both Online and Offline, represents a significant challenge and needs the combined knowledge of Western and Local CHC business models, network, and deal making expertise.
- EBM and TPP have therefore combined their resources to establish China Deal Flow, a new dedicated CHC advisory business that recognises this market need and combines knowledge of Western and Local CHC business models, network, and deal making expertise.